← Leaderboards
Jay H Traverse
University Of Minnesota
$1,908,574
Attributed
$1,908,574
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $592.5K · FY2011–14$1M$750K$500K$250K$0
'11
'12
'13
'14
Funding mix
By agency
NIH$1,908,574 · 1
By mechanism
R01$1,908,574 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Demetris Yannopoulos$17,118,162
- Timothy D Henry$6,994,484
- Douglas Yee$35,505,227
- Lauren D. Black$2,584,697
- Scott A Baker$1,781,018
Others in their field
Top investigators on “Acute”
- Barton F Haynes · Duke University$295,684,085
- Peter C Adamson · National Childhood Cancer Foundation$256,842,224
- Judith S. Currier · University Of California Los Angeles$242,306,415
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$230,305,108
- Lawrence Corey · Fred Hutchinson Cancer Center$204,110,869
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
Research focus
AcuteAcute Myocardial InfarctionAdmission ActivityAngioplastyAngioplasty, Transluminal, Percutaneous CoronaryAnimal ModelAnionsApoptosisAreaArteriesArtery OcclusionBiological AvailabilityBiological PreservationBlood FlowCanis FamiliarisCardiacClinicClinical DataClinical ResearchClinical Trial Protocol DocumentClinical TrialsCongestive Heart FailureCoronaryAbstracting
Grant awards (4)
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI$206,341
R01 · FY2014 · HL · contact PI
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI$541,765
R01 · FY2013 · HL · contact PI
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI$567,987
R01 · FY2012 · HL · contact PI
Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in STEMI$592,481
R01 · FY2011 · HL · contact PI